| 1321/2088 | US=65 / Biol/Mol Lynch CC, Matrisian LM. Matrix metalloproteinases as key regulators of tumor-bone interraction. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 541-66. ISBN 978-0-387-69056-8. |
| 1322/2088 | US=67 / Biol/Mol Azad NS, Sarosy G, Kohn EC. Molecular targets in ovarian cancer and endometrial cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 291-308. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE OVARIO; CANCER ENDOMETRIAL; ALVOS MOLECULARES; TIROSINA-QUINASES; EGFR; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL (VEGF); ONCOGENE; GENES SUPRESSORES DE TUMOR |
| 1323/2088 | US=67 / Biol/Mol Denis GV. Imatinib mesylate (gleevec) and the emergence of chemotherapeutic drug-resistant mutations. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 545-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. QUIMIOTERAPICOS; MUTACOES; RESISTENCIA AOS MEDICAMENTOS; MESILATO DE IMATINIBE; GLEEVEC; STI-571; LEUCEMIA MIELOGENA CRONICA; TUMOR ESTROMAL GASTROINTESTINAL; BCR-ABL; C-KIT; FATOR DE CELULA-TRONCO; BIOLOGIA ESTRUTURAL |
| 1324/2088 | US=67 / Biol/Mol Champaneria MC, Modlin IM, Latich I, Bornschein J, Drozdov I, Kidd M. Somatostatin analogue therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 585-637. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. TERAPIA ANALOGA DA SOMATOSTATINA; ACROMEGALIA; CARCINOIDE; SINDROME CARCINOIDE; HORMONIO DE CRESCIMENTO; LUTECIO; OCTREOTIDE; NEUROENDOCRINO; PROLIFERACAO; CINTILOGRAFIA; RECEPTOR DE SOMATOSTATINA; SOMATULINA; TUMOR; ITRIO |
| 1325/2088 | US=58 / Câncer Le XF, Bast Junior RC. p27Kip1 as a biomark and target for treatment of cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 215-33. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. P27KIP1; CICLO CELULAR; SUPRESSOR DE TUMOR; TERAPIA ALVO; TRASTUZUMAB |
| 1326/2088 | US=7 / Tórax Camargo JJ. Tratamento cirúrgico do carcinoma brônquico. In: Tarantino AB. Doenças pulmonares. 6ª ed. Rio de Janeiro: Guanabara Koogan, 2008. p. 608-25. ISBN 85-2771333-7. CARCINOMA BRONQUICO; CANCER DE PULMAO; CIRURGIA; ESTADIAMENTO DO TUMOR |
| 1327/2088 | US=7 / Tórax Camargo JJ. Outras neoplasias do pulmão. In: Tarantino AB. Doenças pulmonares. 6ª ed. Rio de Janeiro: Guanabara Koogan, 2008. p. 626-37. ISBN 85-2771333-7. CONDRO-ADENOMA; HAMARTOMA; HAMARTOMA CONDROMATOSO; ADENOMA BRONQUICO; TUMORES CARCINOIDES; CARCINOMA ADENOIDE CISTICO; CILINDROMA; TUMOR MUCOEPIDERMOIDE; CARCINOMA MUCOEPIDERMOIDE; ADENOMA DE GLANDULAS MUCOSAS BRONQUICAS; GRANULOMA DE CELULAS PLASMATICAS; HEMANGIOMA ESCLEROSANTE; FIBROMA; CONDROMA; LIPOMA; LIOMIOMA |
| 1328/2088 | US=70 / Biol/Mol Bunz F. Tumor suppressor genes. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 77-124. ISBN 978-1-4020-6783-9. GENES SUPRESSORES DE TUMORES; FENOTIPO RECESSIVO; RETINOBLASTOMA; HIPOTESE DE KNUDSON; LOCALIZACAO CROMOSSOMICA DO GENE; INATIVACAO DO P53; SINDROME DE LI-FRAUMENI; SUSCETIBILIDADE; CANCER DE MAMA; BRCA1; BRCA2; CDKN2A; PTEN; SMAD4; NEUROFIBROMATOSE; NEOPLASIA ENDOCRINA MULTIPLA TIPO 1; SINDROMES DE CANCER EM CAMUNDONGOS |
| 1329/2088 | US=8 / Dermatologia Dlugosz A, Yuspa SH. Carcinogenesis: chemical. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 358-67. ISBN 978-0-07138076-0. CARCINOGENESE; QUIMICA; CANCER DE PELE; SAUDE PUBLICA; CARCINOGENOS QUIMICOS; SINDROMES HEREDITARIAS DE CANCER; NEOPLASIAS CUTANEAS; BIOLOGIA DO TUMOR; BIOQUIMICA |
| 1330/2088 | US=8 / Dermatologia Shea CR, Prieto VG. FIbrous lesions of dermis and soft tissue. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 988-1001. ISBN 978-0-07138076-0. LESOES DE TECIDO FIBROSO; LESOES DA DERME; LESOES DE TECIDOS MOLES; FIBROMATOSE; TUMOR DESMOIDE; HAMARTOMA; NEOPLASIAS |
| 1331/2088 | US=8 / Dermatologia Albrecht S. Neoplasias and hyperplasias of neural and muscular origin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1032-41. ISBN 978-0-07138076-0. NEOPLASIAS; HIPERPLASIAS; TUMORES MUSCULO-ESQUELETICOS; HAMARTOMA NEUROMUSCULAR; HAMARTOMA MESENQUIMAL RHABDOMIOMATOSO; RABDOMIOMA; RABDOMIOSSARCOMA; TUMORES DO MUSCULO LISO; LEIOMIOMA; LEIOMIOSSARCOMA; NEUROMA; NEOPLASIAS BENIGNAS DA BAINHA DOS NERVOS; SCHWANNOMA; NEUROFIBROMA; NEUROTEQUEOMA; PERINEURIOMA; NEOPLASIAS MALIGNAS DA BAINHA DOS NERVOS; TUMOR DE CELULAS GRANULARES; MENINGIOMA; EPENDIMOMA MIXOPAPILAR; GANGLIONEUROMA; HETEROTOPIA CEREBRAL |
| 1332/2088 | US=80 / Biol/Mol Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA |
| 1333/2088 | US=80 / Biol/Mol Annunziata CM, Roque DM, Azad N, Kohn EC. Application of serum and tissue proteomics to understand and detect solid tumors. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 101-20. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. PROTEOMICA; ENSAIO CLINICO; TUMOR SOLIDO; ESPECTROMETRIA DE MASSA; TISSUE MICROARRAY |
| 1334/2088 | US=80 / Biol/Mol Brünner N, Holten-Andersen M, Sweep F, Foekens J, Schmitt M, Duffy MJ. New tumor biomarkers. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 189-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. BIOMARCADORES TUMORAIS; PRE-ANALITICA VARIAVEIS; VARIAVEL ANALITICA; POS-ANALITICA VARIAVEL; MARCADORES DE DETECCAO DE MARCADORES DE TRIAGEM; MARCADORES PROGNOSTICOS; MARCADORES PREDITIVOS; MARCADORES DE MONITORAMENTO |
| 1335/2088 | US=84 / Biol/Mol Kim SS, Shuman C, Mishra L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: Interaction of smad4 and embryonic liver fodrin-B-spectrin in hyperplasia, neoplasia, and tumor suppression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 91-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD4; CAMUNDONGOS KNOCKOUT; TUMORIGENESE; FATOR TRANSFORMADOR DE CRESCIMENTO |
| 1336/2088 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: nuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 125-37. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. IMPORTACAO NUCLEAR; EXPORTACAO NUCLEAR; NUCLEO-CITOPLASMATICO; SMAD; TGF-B |
| 1337/2088 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: ski, snoN, and aKt as negative regulators of smad activity: balancing cell death and cell survival regulatorsnuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 139-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 1338/2088 | US=84 / Biol/Mol Stuelten CH, Roberts AB, Stetler-Stevenson WG. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: functional interactions between MMPs and TGF-B in normal and tumor tissue. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 275-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; MMP; TUMOR; INTERACAO ESTROMA TUMORAL; SINALIZACAO CELULAR |
| 1339/2088 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |
| 1340/2088 | US=84 / Biol/Mol MacLaughlin DT, Donahoe PK. TGF-B superfamily members in normal and tumor biology: mullerian inhibiting substance: a potencial nontoxic, naturally occurring therapeutic agent for certain human cancers. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 333-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |